IL7 and neoplasm: Upon administration, we suspect that these IL-21/IL-2-expanded TILs or TRUCKs would be best maintained by engineering them to secrete IL-7 and IL-15, which we hypothesize will further promote their persistence and memory recall responses to prevent tumor relapse in patients.